Imagen de Portada

Comment on “Delirium event and associated treatment modifications among older adults with Alzheimer's disease: An interrupted time‐series analysis of Medicare data”

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Shih‐Jie Wang, Lien‐Chung Wei, Hsien‐Jane Chiu
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Delirium event and associated treatment modifications among older adults with Alzheimer's disease: An interrupted time‐series analysis of Medicare data
por: Ashna Talwar, et al.
Publicado: (2024)

Prevalence of potentially inappropriately prescribed medications among older adults receiving peritoneal dialysis
por: Armando Silva Almodovar, et al.
Publicado: (2025)

Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics
por: Trisha Matsuura, et al.
Publicado: (2025)

Thirty‐day risk of digoxin toxicity among older adults co‐prescribed trimethoprim‐sulfamethoxazole versus amoxicillin: A population‐based cohort study
por: Flory T. Muanda, et al.
Publicado: (2024)

Comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”
por: João Gama Marques, et al.
Publicado: (2025)

Albuminuria‐based stratification of end‐stage kidney disease progression and mortality with sodium‐glucose cotransporter 2 inhibitors (SGLT2i): A retrospective cohort study in type 2 diabetes and chronic kidney disease
por: Tien‐Jyun Chang, et al.
Publicado: (2024)

Prevalence of prescription medication use that can exacerbate heart failure among US adults with heart failure
por: Alexander R. Zheutlin, et al.
Publicado: (2025)

Use of proton pump inhibitors and risk of severe COVID‐19: A case–control study in United States Medicare beneficiaries
por: Andrew D. Mosholder, et al.
Publicado: (2024)

Antiviral influenza treatments and hemorrhage‐related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database
por: Jyotirmoy Sarker, et al.
Publicado: (2024)

Comment on “The power and pitfalls of underpowered studies”
por: Chia Siang Kow, et al.
Publicado: (2024)

Genome‐wide associations with metabolic syndrome among UK Biobank participants reporting use of second‐generation antipsychotics
por: Nihal El Rouby, et al.
Publicado: (2025)

Simulated cost‐effectiveness of a novel precision‐guided dosing strategy in adult patients with Crohn's disease initiating infliximab maintenance therapy
por: Elmar R. Alizadeh, et al.
Publicado: (2024)

Combination eravacycline therapy for ventilator‐associated pneumonia due to carbapenem‐resistant Acinetobacter baumannii in patients with COVID‐19: A case series
por: Melissa N. W. Jackson, et al.
Publicado: (2024)

Comment on “Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution”
por: Yongyi Zhang, et al.
Publicado: (2024)

Response to Comment on “Acute Pharmacodynamic Effects of Oral Levodopa on Blood Pressure in Parkinson’s Disease”
por: Katherine Longardner, et al.
Publicado: (2026)

Comment on “C‐Reactive Protein and Neutrophil‐to‐Lymphocyte Ratio: Can They Be Used Interchangeably in Tracking Clozapine‐Related Inflammation?”
por: Yuki Kikuchi
Publicado: (2026)

Comment on “Proton Pump Inhibitor Concomitant Use to Prevent Oxaliplatin‐Induced Peripheral Neuropathy: Clinical Retrospective Cohort Study”
por: Majid Khalilizad, et al.
Publicado: (2025)

Response to Comment on “Proton Pump Inhibitor Concomitant Use to Prevent Oxaliplatin‐Induced Peripheral Neuropathy: Clinical Retrospective Cohort Study”
por: Keisuke Mine, et al.
Publicado: (2025)

Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population
por: Alexandre Duong, et al.
Publicado: (2024)

Update and narrative review of avian influenza (H5N1) infection in adult patients
por: Mohammed Aldhaeefi, et al.
Publicado: (2024)

Belzutifan's role in the treatment landscape of clear cell renal cell carcinoma
por: Adrienne H. Chen, et al.
Publicado: (2025)

Adverse events with co‐prescription of angiotensin receptor blockers and clarithromycin compared to azithromycin: A population‐based retrospective cohort study
por: Nicholas C. Tonial, et al.
Publicado: (2025)

“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists’”
por: Carlos Augusto Espinoza Cobeñas
Publicado: (2024)

Updates in chronic kidney disease management: A systematic review
por: Amina Ammar, et al.
Publicado: (2025)

Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
por: Yi‐Fan Chien, et al.
Publicado: (2025)

Response to Comment on “Establishing discordance rate of estimated glomerular filtration rate between serum creatinine‐based calculations and cystatin‐C‐based calculations in critically ill patients”
por: Victoria L. Williams, et al.
Publicado: (2025)

Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report
por: Atif Siddiqui
Publicado: (2024)

Neurodevelopmental outcomes in children prenatally exposed to opioid maintenance treatment: A population‐based study
por: Mennatullah Hasan, et al.
Publicado: (2024)

Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”
por: Atif Siddiqui
Publicado: (2025)

Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case‐cohort
por: Eleonora Camilleri, et al.
Publicado: (2024)

Pain management considerations in patients living with both pain syndromes and cardiovascular diseases and disorders
por: Emily E. Leppien, et al.
Publicado: (2024)

Multicenter study evaluating target attainment of anti‐Factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients
por: Tyler Chanas, et al.
Publicado: (2024)

Efficacy and safety of mirikizumab compared with currently approved biologic drugs for the treatment of ulcerative colitis: A systematic review and network meta‐analysis
por: Paweł Moćko, et al.
Publicado: (2024)

Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy
por: David B. Cluck, et al.
Publicado: (2024)

Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists
por: Elizabeth M. Sherman, et al.
Publicado: (2024)

Correction to “Risk of incident antidepressant‐treated depression associated with use of 5α‐reductase inhibitors compared with use of α‐blockers in men with benign prostatic hyperplasia: A population‐based study using the Clinical Practice Research Datalink”
Publicado: (2024)

Assessment of the association between mixed‐oil lipid injectable emulsion use and 30‐day mortality or infection persistence from fungal catheter‐related bloodstream infections in pediatric patients following receipt of parenteral nutrition: A retrospective cohort study
por: Gustavo R. Alvira‐Arill, et al.
Publicado: (2025)

Thrombosis Across Female‐Specific Malignancies: From Chemotherapy‐Driven Risk to Prophylaxis and Drug Interactions
por: Maryam Aghakouchakzadeh, et al.
Publicado: (2026)

Cancer Treatment Modalities and Female Fertility Preservation
por: Seonga Song, et al.
Publicado: (2026)

Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens
por: Mohammed Al Musawa, et al.
Publicado: (2024)